South Korea's liquor companies performed poorly in 2020 as people consumed less alcohol due to the coronavirus outbreak, data showed Wednesday.
Sales of Lotte Chilsung Beverage Co., a major beer and soju brewer and beverage manufacturer, shrunk 7.7 percent on-year to 2.16 trillion won last year. Lotte Chilsung also reported an operating income of 97.2 billion won in 2020, down 10.8 percent from 2019.
Oriental Brewery (OB) Co., South Korea's largest brewer, suffered a 12.3 percent on-year decrease in sales to 1.35 trillion won last year, with its operating profit plunging 28 percent to 294.5 billion won.
The country's whisky makers also took a bigger hit from the coronavirus pandemic as bars were forced to cut operating hours and suspend operations.
Golden Blue's whisky sales tumbled 24.8 percent on-year to 127 billion won last year, with its operating income dropping 5.2 percent to 20.2 billion won.
Sales of Diageo Korea Co. plunged 32.6 percent on-year to some 200 billion won as its operating income plummeted by around 60 percent to 20 billion won.
Meanwhile, Pernod Ricard Korea's sales also fell 11.7 percent on-year to 91.5 billion won but recorded an operating profit of 16.1 billion won.
Hite Jinro Co. was the only South Korean liquor maker that did well, thanks to the popularity of its new products. Its sales soared 12 percent on-year to 2.05 trillion won last year, with its operating income surging 125.2 percent to 180.8 billion won.


South Korea Central Bank Warns of Rising Financial Stability Risks Amid Won Volatility
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Asian Markets Rise as AI Rally Caps 2025, Gold and Silver Hit Record Highs
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
US and Japan Fast-Track $550 Billion Strategic Investment Initiative
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Oil Prices Ease in Asia as Geopolitical Risks Clash With Weak Demand Outlook
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
China Keeps Benchmark Lending Rates Steady as Economic Outlook Remains Cautious
U.S. Stocks Rally to Record Highs as AI Rebound Fuels Holiday-Shortened Session
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
UK Economy Grows 0.1% in Q3 2025 as Outlook Remains Fragile
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies 



